Despite knowledge of the primary genetic defects and well-documented histopathology associated with FKRP-related dystroglycanopathies, the biomolecular pathogenesis linking the genotype to the wide variation in phenotypes remains poorly understood. This evidence concerns the gene FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.